Summary:

Financing will advance its musculoskeletal product through a clinical proof of activity trial as well as continue the discovery and development of its ongoing pipeline of microbial-based products for human health and well-being.

Article written by Unknown

19|10|2020

Source:

PR Newswire

https://www.prnewswire.com/news-releases/solarea-bio-announces-series-a-financing-led-by-s2g-ventures-and-bold-capital-partners-301154473.html

Pin It on Pinterest